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Abstract 
Choo YC, Naylor B (Division of Gynecologic 
Oncology, Department of Obstetrics and 
Gynecology, and Department of Pathology, 
University of Michigan Hospital, Ann Arbor, 
MI, USA). Multiple primary neoplasms of 
the ovary and uterus. 
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Multiple primary neoplasms arising in the 
ovary and uterus were analyzed in 55 patients.. 
49 synchronous and 6, metachronous. When 
they occurred synchronously, 74.5% of the 
ovarian carcinomas and 93.6% of the uterine 
carcinomas were stage I lesions. The endo- 
metrial carcinomas were invariably well differ- 
entiated and superficial. It was the stage 
of the ovarian carcinomas that determined 
the prognosis of these patients. Ways of 
their identification as separate neoplasms 
are discussed. The potential to develop 
further neoplasms in the gastrointestinal 
tract and breasts should be borne in mind. 
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Introduction 
Multiple neoplasms in the ovary and 
uterus may arise as a result of estrogenic 
influence from a functioning ovarian tumor 
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[ 1 ] , or when a hormonally active stroma is 
present in an epithelial ovarian carcinoma 
[2]. In addition, despite their distinct and 
separate development, both the ovaries and 
uterus receive contribution from the celomic 
epithelium which forms the ovarian germinal 
epithelium as well as the endometrium. Such 
an embryologically-derived field, when sub- 
jected to a common carcinogen, may also 
give rise to multiple neoplasms [31. The 
identification of neoplasms in the ovary and 
uterus, as being separate, is clear-cut when 
the histology is dissimilar, when the his- 
tology is identical, no definite criteria exist, 
however, in their distinction as to whether 
they are independent or metastatic neo- 
plasms. Although such entities are not a 
rarity, reports on multiple neoplasms of 
the ovary and uterus are scarce [3-51. Also, 
it is not uncommon to encounter patients 
diagnosed as having ovarian carcinomas 
metastatic to the uterus or vice versa who 
have survived many years, suggesting that 
perhaps these neoplasms are of different 
origin. We undertook a retrospective study 
on patients with multiple neoplasms in the 
ovary and uterus encountered during a 
27.5-year period with a view to review their 
clinical and pathological features and to 
establish guidelines for their identification. 
Materials and methods 
The data were obtained from the Tumor 
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Registry of the University of Michigan 
Hospital on all patients who had multiple 
neoplasms of the ovary and uterus diagnosed 
between January 1943 through June 1980. 
The patients’ records were analyzed with 
respect to their presentation, diagnosis, 
treatment and follow-up. The pathology 
slides were reviewed and the findings corre- 
lated with that at surgery. Fifty-nine patients 
were identified; five were excluded after 
analysis because actual evidence of separate 
neoplasms could not be established. Thus 
synchronous neoplasms in the ovary and 
uterus were found in 49 patients and meta- 
chronous neoplasms in six patients. Although 
the study embraced such a long period, most 
patients were identified within the past 
decade. In order to establish criteria for their 
identification as separate origin, observations 
were focused on the following: (1) operative 
findings; (2) morphology of the two neo- 
plasms; (3) the extent of endometrial neo- 
plasm and its association with hyperplasia, 
atypia and carcinoma in situ; (5) transition 
of the ovarian carcinoma from germinal 
epithelium; and (6) the stroma of the ovary. 
Results 
A. Synchronous multiprimary neoplasms of 
the ovary and uterus 
The patients’ ages ranged from 27 years 
to 81 years, with a mean of 54.6. Their 
parity ranged from 0 to 7, the average 
being 2.1 Fourteen patients (28.6%) were 
nulliparous, and 31 (63.0%) were postmeno- 
pausal. Obesity, diabetes and hypertension 
were not signiticant findings as was the family 
history of cancer. Exogenous estrogen was 
recorded in eight patients. 
The most common symptom was abnormal 
uterine bleeding, noted in 20 patients 
(40.8%), while abdominal discomfort, bloat- 
ing and distension were the complaints in 
13 patients (26.5%). Only eight patients 
(16.3%) had both uterine bleeding and 
abdominal symptoms. Three patients pre- 
sented with acute abdomen and three patients 
were completely asymptomatic. The most 
common finding was an enlarged uterus, 
recorded in 14 patients (28.6%). Thirteen 
patients (26.5%) had an ovarian tumor 
palpable and separate from a normal sized 
uterus. Findings of dual pathology of an 
enlarged uterus and an ovarian mass were 
noted in only three patients. 
The pre-treatment diagnoses are shown in 
Table I. Twenty-four patients were diagnosed 
as having endometrial carcinoma following a 
D &C; of those, seven (14.3%) had a diag- 
nosis of ovarian tumor as well because of a 
palpable ovarian mass. In ten patients, the 
sole diagnosis was ovarian neoplasm. In ten 
other patients, the diagnosis varied and 
included fibroid, carcinoma of the colon, 
torsion of the ovary, acute appendicities and 
diverticular abscess. 
At surgery, 45 patients were found to have 
a uterus that was mobile and grossly un- 
involved by the ovarian neoplasm. On the 
basis of dissimilar histology, 22 patients 
were diagnosed as having two neoplasms 
arising in the ovary and uterus. Figures 1 
and 2 illustrate such an example. In the 
remaining 27 patients with neoplasms of 
identical histology, 25 has endometrioid 
carcinoma of the ovary associated with 
adenocarcinoma of the uterus. Recognition 
of variable patterns and grades led to further 
categorization of the neoplasms as separate 
in 12 of these patients (Figs. 3 and 4). In 
nine patients, a primary adenocarcinoma 
arising in the uterus was evident by the 
presence of associated atypia and carcinoma 
in situ, or by its origin in endometrial polyps. 
Table I. Synchronous ovarian and uterine neoplasms, 
pre-treatment diagnosis. 
Uterine carcinoma 17 
Uterine carcinoma and ovarian mass 7 
Ovarian neoplasm 10 
Pelvic mass, undetermined 5 
Miscellaneous 10 
TOTAL 49 
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Fig. 1. Ovary. Moderately differentiated papillary serous cystadenocarcinoma of ovarian origin (1 H & E, x83). 
Fig. 2. Endometium Moderately differentiated adenocarcinoma which originated in endo 
distinct from the ovarian lesion (H & E, X83). 
metrium. It is morphologic 2llly 
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Fig. 3. Ovary. Moderately differentiated adenocarcinoma of ovarian origin (H & E, X 132). 
Fig. 4. Endometriz~m Well differentiated adenocarcinoma of endometrial origin (H & E, X 13 
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Six patients with endometrioid carcinoma 
of the ovary had evidence of malignant 
transformation from endometriosis or transi- 
tion from an inclusion cyst and cystadenoma. 
The histology of the uterine neoplasms 
is shown in Table II. Forty-seven were adeno- 
carcinomas and two were leiomyosarcoma. 
The endometrial carcinomas were well differ- 
entiated in 37 patients (78.8%), they were 
focal, confined to the endometrium or 
invading less than one-third of the endo- 
metrium in 32 patients (68.1%). 
The most common ovarian carcinoma 
was endometrioid, identified in 25 patients 
(5 1 .O%), followed by serous cystadeno- 
carcinoma in 16 patients (32.6%). Bilateral 
ovarian carcinomas., most commonly serous 
variety, occurred in 14 patients (28.6%) 
(Table III). Stromal hyperplasia in the 
neoplastic or normal ovary was noted in 
five patients (10.2%) (Fig. 5). 
When the uterine and ovarian carcinomas 
were independently staged, it was found 
that 44 patients (93.6%) had stage I endo- 
metrial carcinomas, of which 32 (68.1%) were 
IAGl lesions, and 35 patients (74.5%) had 
stage I carcinomas of the ovary. 
The treatment modalities although varied, 
were conventional. Surgery and postoperative 
irradiation were the most common treatment 
employed (24 patients), and 11 patients 
received adjunctive chemotherapy as well. 
Table 2. Synchronous ovarian and uterine neoplasms, 
histology of uterine neoplasms. 
Well Moderately Poorly 
differ- differ- differ- 
entiated entiated en&ted 
Total 
Adeno- 
carcinoma 32 I 1 40 
Acantho- 
adeno Ca 5 1 1 7 
Leiomyo- 
sarcoma 2 
TOTAL 31 8 2 49 
Table 3. Synchronous ovarian and uterine neoplasms, 
histology of ovarian neoplasms. 
Unilateral Bilateral Total 
Endometrioid Ca 21 4 25 
Serous cystadeno Ca 9 I 16 
Mutinous cystadeno Ca 2 0 2 
Clear cell Ca 1 1 2 
Mixed epithelial Ca 2 2 4 
TOTAL 35 14 49 
- 
Overall, 42 patients were available for 3- 
and 5-year survival analysis. The 3- and 
5-year corrected survivals were 83.3% and 
73.8%, respectively. Among the 33 patients 
with stage I ovarian and uterine carcinoma, 
the corresponding 3- and 5-year corrected 
survivals were 87.5% and 78.1%, respectively. 
B. Metachronous multiprimary neoplasms of 
the ovary and uterus 
Sequential multiprimary neoplasms were 
found in six patients. In five patients, the 
initial neoplasm was ovarian and a second 
carcinoma arose in the retained uterus after 
a mean interval of 6.5 years, four of them had 
been given postoperative pelvic irradiation as 
well. A hormonal factor may also be operative 
in two of them as one patient had a malignant 
thecoma and the other received stilbesterol 
for a prolonged duration. The uterine carcino 
mas in all these patients were stage I, and at 
hysterectomy none had demonstrable resi- 
dual ovarian neoplasm. Three of the patients 
have died of intercurrent disease and the 
other two are alive at 3 years and 7 years, 
respectively. In the sixth patient, the initial 
carcinoma was uterine, and 14 years later, 
a stage IV ovarian carcinoma was found. 
Significantly, her initial uterine carcinoma 
was treated with irradiation only. 
Of the entire series of 55 patients with 
synchronous and metachronous neoplasms 
of the ovary and uterus, seven (12.7%) have 
developed additional neoplasms elsewhere 
for a total of ten carcinomas (Table IV). The 
most common site was the colon followed by 
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Fig. 5. Ovary. Cortical stromal hyperplasia (H & E, X 5 3). 
the breast. It is noteworthy that in one 
patient, initial simultaneous carcinomas 
arising in the right colon, ovary and uterus 
were found, and 7 years and 10 years later, 
she developed a fourth and fifth carcinoma 
in the stomach and sigmoid colon, all success- 
fully treated. 
Discussion 
Neoplasms arising in the ovary and uterus 
are not always associated with the presence 
of a functioning ovarian tumor. Only one 
malignant thecoma was identified in our 
series while the rest of the ovarian neoplasms 
Table 4. Synchronous and metachronous ovarian and 
uterine neoplasms, additional neoplasms in seven patients. 
Colon Ca 3 
Breast Ca 2 
Stomach Ca 1 
Jejunum, Ca 1 
Appendix, Ca 1 
Cervix, Ca 1 
Bladder Ca 1 
were epithelial in origin. Epithelial tumors, 
however, may be estrogenic when stromal 
hyperplasia is present. This was found in only 
10.2% of our patients. Rome [6] reported 
a higher incidence of stromal hyperplasia in 
epithelial carcinomas arising in postmeno 
pausal ovaries. Such a phenomenon is said to 
be a response to the mechanical presence of 
the epithelial carcinoma [21. Woodruff [31 
postulated that multiple malignancies of the 
ovary and uterus may arise in a commonly- 
derived epithelium due to carcinogenic 
influence. This may well happen in 
patients who develop bilateral ovarian 
carcinomas simultaneously with endometrial 
carcinomas. It should also be realized that 
carcinogenesis from radiation treatment is a 
possibility as this could not be discounted in 
five of our six patients who developed a 
metachronous carcinoma in the retained 
uterus or ovary. 
It should be noted that symptoms and 
signs suggesting dual neoplasms in the ovary 
and uterus are often absent and their diag- 
nosis are seldom made preoperatively. Such 
a suspicion should be raised when a patient 
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is found to have endometrial carcinoma 
and an ovarian mass is also palpable. It is 
also significant that 21 of our patients 
(42.9%) had no bleeding whatsoever, this 
perhaps is attributable to an early endometrial 
carcinoma. It is therefore mandatory in an 
occasional young patient who has ovarian 
carcinoma and in whom conservation of the 
uterus may be a consideration, that a diag- 
nostic D &C be performed to exclude an 
occult endometrial carcinoma. In most 
other situations, the treatment for an ovarian 
malignancy should be the extirpation of the 
ovaries and uterus lest a carcinoma should 
develop in the retained uterus. 
When an ovarian tumor is found to occur 
in association with endometrial carcinoma, 
an exploratory laparotomy should be initi- 
ated. Following surgery, adjuvant irradiation 
and/or chemotherapy may then be instituted. 
The categorization of their origin when the 
ovarian and uterine carcinomas are of similar 
histology is not at all simple; this is especially 
true of endometrioid carcinoma of the ovary 
associated with an adenocarcinoma of the 
uterus. Kottmeier [7] reported that one- 
third of all patients with endometrioid 
carcinoma of the ovary had concomitant 
adenocarcinoma of the endometrium. At 
surgery, one should therefore clearly define 
whether the uterus and ovaries are free of 
contiguous spread by neoplasm. Endometrial 
carcinoma that arises de ytovo is suggested by 
finding hyperplasia, atypia and carcinoma 
in situ as well. The endometrial component 
in such cases is invariably well differentiated, 
focal and superficial. It is well known that 
the fallopian tube may serve as a conduit for 
the spread of a carcinoma from the uterus to 
the ovary [8] . The ovary may then be secon- 
darily involved by extracapsular implants but 
there would be no transition of the surface 
epithelium. Endometriosis is commonly found 
in association with endometriod carcinoma 
of the ovary, and one should look for its 
malignant transformation. Noting for dis- 
parity between the grade and pattern of the 
two neoplasms requires careful pathological 
evaluation, and when present, it is evi- 
dence to regard both neoplasms as having 
separate origins. When both neoplasms are 
anaplastic, however, such a distinction is 
not always possible, and one has to regard 
the neoplasms as metastatic especially when 
deep myometrial invasion is also evident. 
The excellent survival of these patients is 
further evidence that the neoplasms are of 
independent origin, for if the neoplasms are 
metastatic, the prognosis should be correspon- 
dingly poor. One should also note that 
since the uterine carcinomas are often well 
differentiated and superficial, it is the stage 
of the ovarian carcinomas that ultimately 
determines the prognosis and survival of 
these patients. 
Our study, as well as others [9-l 11, has 
shown that multiple primary neoplasms may 
not only develop in the ovary and uterus 
but they also commonly occur in association 
with carcinomas in the gastrointestinal tract 
and breast. Such an awareness is essential 
in the evaluation and follow-up of these 
individuals. 
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